Gram Research analysis of a 2026 study found that a higher fasting glucose-to-HDL cholesterol ratio, a simple blood test marker, was linked to a 22% higher risk of developing MASLD (fatty liver disease) in nonobese Chinese adults. Among 16,173 participants, the highest-ratio group had about twice the risk of the lowest group.
Gram Research analysis of a large Chinese health study suggests that a simple blood test ratio may help spot early fatty liver disease before symptoms appear. Researchers tracked 16,173 adults who were not overweight, all with a body mass index below 25. The ratio compares fasting blood sugar to HDL cholesterol, often called “good” cholesterol. Over the follow-up period, 2,322 people developed fatty liver disease, which doctors now call MASLD. Adults with the highest ratios had about twice the risk of those with the lowest. Each small step up in the ratio was linked to a 22% higher risk. The ratio is inexpensive and uses routine bloodwork, but it is not yet a standard diagnostic tool, and the findings come from one region in China.
Key Statistics
A 2026 retrospective cohort study of 16,173 nonobese Chinese adults found that each 1-unit increase in the fasting glucose-to-HDL cholesterol ratio was linked to a 22% higher risk of developing fatty liver disease.
In the same 2026 study, adults in the highest quartile of the fasting glucose-to-HDL cholesterol ratio had a hazard ratio of 2.10 for developing fatty liver disease compared with those in the lowest quartile.
The 2026 study reported that the ratio had a moderate predictive ability for fatty liver disease, with an area under the curve of 0.701 and an optimal cutoff value of 3.87.
The Quick Take
- What they studied: Researchers asked whether a simple blood test ratio, comparing fasting blood sugar to HDL (“good”) cholesterol, could predict who will develop fatty liver disease in people who are not overweight.
- Who participated: The study included 16,173 adults from Wenzhou, China, who had a body mass index below 25 and no fatty liver disease at the start. They were part of a routine health screening program.
- Key finding: Each 1-unit increase in the ratio was linked to a 22% higher chance of developing fatty liver disease. People in the top quarter of ratio scores had about twice the risk (hazard ratio 2.10) of people in the bottom quarter. The ratio correctly sorted people by risk about 70% of the time, which is moderate accuracy.
- What it means for you: If you are not overweight, your fasting blood sugar and HDL cholesterol results may offer an early hint about your liver health. The ratio is not a diagnosis. Talk with your doctor about liver ultrasounds or other tests if your ratio is high, and focus on habits that support healthy blood sugar and cholesterol.
The Research Details
This was a retrospective cohort study, meaning researchers looked back at existing health records rather than enrolling new people and following them forward from the start. They used data from the Wenzhou Health Examination Cohort, a large group of adults who had routine checkups. Only people without fatty liver disease at the beginning were included, so the researchers could track who developed it later.
At the start, each person’s fasting glucose-to-HDL cholesterol ratio was measured and the group was split into four equal parts, called quartiles, from lowest to highest ratio. Fatty liver disease was diagnosed with abdominal ultrasound, a common imaging test that uses sound waves to view the liver. Researchers then compared how often people in each group developed the disease.
To make the comparisons fairer, the team statistically adjusted for other factors that can affect liver health, such as age, sex, blood pressure, and other metabolic measures. They also used special statistical models to check whether higher ratios consistently meant higher risk, and a prediction test to see how well the ratio could separate people who would and would not develop the disease.
Looking at people over time is useful because it shows what came first. Since the ratio was measured before fatty liver disease appeared, the results are more meaningful than a single snapshot would be. Adjusting for other factors helps rule out some explanations, although it cannot remove every possible influence. Using a large group also gives more confidence that the pattern is real and not due to chance.
The study has several strengths: a large sample of more than 16,000 people, a clear before-and-after design, statistical adjustment for many factors, and a dose-response pattern, meaning risk rose steadily as the ratio went up. The results were published in a peer-reviewed journal. However, the study is based on existing records, so the quality of the data depends on how carefully it was collected. Fatty liver disease was identified by ultrasound, which is useful but can miss mild cases. Readers should view the findings as strong evidence of an association, not proof that the ratio causes liver disease.
What the Results Show
The main finding was that higher fasting glucose-to-HDL cholesterol ratios were linked to a greater chance of developing fatty liver disease. In the fully adjusted analysis, each 1-unit increase in the ratio was associated with a 22% higher risk (hazard ratio 1.22, 95% confidence interval 1.17 to 1.27). A confidence interval is a range that shows where the true effect likely falls, and this narrow range suggests the estimate is fairly precise.
When researchers grouped participants into quartiles, the pattern was clear. People in the highest quartile had a hazard ratio of 2.10 compared with the lowest quartile, meaning roughly double the risk. The increase in risk followed a consistent trend from one group to the next, which strengthens the case that the relationship is real.
The researchers also found a positive dose-response relationship. This means that the more the ratio rose, the more the risk rose, without a sudden jump at one point. This type of pattern is often seen when a factor is genuinely connected to a condition.
Finally, the team tested how well the ratio could predict who would develop the disease. The area under the curve was 0.701, which indicates moderate predictive ability. The best cutoff point they identified was 3.87. This means the ratio is useful for sorting people by risk, but it is far from perfect on its own.
The study focused on people who were not overweight, which is important because fatty liver disease is often assumed to affect mainly people with obesity. The results suggest that metabolic changes, reflected in blood sugar and cholesterol, may play a role even in leaner adults. This points to the value of checking metabolic health regardless of body size.
Because the ratio uses two common, low-cost blood measurements, it could be added to routine checkups in places where advanced liver tests are limited. The authors suggest it could serve as an early screening signal, prompting further testing for people whose results are concerning.
Fatty liver disease is strongly tied to insulin resistance, blood sugar problems, and low HDL cholesterol in earlier research. This study fits that picture by combining two of these markers into one simple number. Previous work has often focused on people with obesity, so the finding that the ratio matters in nonobese adults adds useful information. Still, the study does not yet show that the ratio outperforms other established markers, so it should be seen as a complement to existing tools.
The study was retrospective, so it relied on records that were not originally collected for research. It included adults from one city in China, which limits how well the results apply to people of other ethnic backgrounds, diets, or healthcare systems. Fatty liver disease was diagnosed by ultrasound, which can miss mild cases and depends partly on the operator’s skill. The ratio was measured at one point in time, so changes over the years were not fully captured. The predictive accuracy was moderate, meaning many people with high ratios will not develop the disease, and many with low ratios might. Finally, the study shows association, not cause and effect. Other unmeasured factors, such as diet, physical activity, or alcohol use, may have influenced the results.
The Bottom Line
Research suggests that a higher fasting glucose-to-HDL cholesterol ratio is linked to higher risk of fatty liver disease in nonobese adults. Confidence in the association is fairly high because the study was large and well adjusted. Confidence in using the ratio as a standalone screening tool is moderate, since its predictive accuracy is only moderate. Adults with a high ratio may benefit from discussing liver health with a doctor, who may order an ultrasound or other liver tests. Practical habits that support healthy blood sugar and cholesterol, such as regular physical activity, balanced meals, and limiting sugary drinks, are widely supported by evidence and are reasonable steps regardless of the ratio.
Adults who are not overweight and have routine blood tests may find this research most relevant, especially if their blood sugar or HDL cholesterol results are borderline. Doctors and health screening programs may find it useful as an added signal. People with obesity, diabetes, or known liver disease already have established care plans and should follow their clinicians’ guidance rather than relying on this ratio alone. People outside the study population should be cautious about applying the exact cutoff value of 3.87, since it may differ across groups.
A blood ratio is a snapshot of current risk, not a treatment, so it will not change on its own within a few weeks. If your ratio is high, your doctor may recommend retesting over several months. Lifestyle changes such as more physical activity, better eating patterns, and modest weight management can improve blood sugar and cholesterol within about 3 to 6 months, though liver changes can take longer to show up on imaging. Consistent habits over one to two years are typically needed to see clear, lasting improvement.
Frequently Asked Questions
What is the fasting glucose-to-HDL ratio and why does it matter for the liver?
The fasting glucose-to-HDL ratio divides your fasting blood sugar by your HDL, or “good,” cholesterol. A 2026 cohort study of 16,173 adults linked higher ratios to a greater risk of fatty liver disease, suggesting it may reflect broader metabolic health.
Can fatty liver disease happen to people who are not overweight?
Yes, fatty liver disease can occur in people with a body mass index below 25. A 2026 study of nonobese Chinese adults found that 2,322 participants developed the condition during follow-up, with risk rising as the blood ratio increased.
Is a high fasting glucose to HDL ratio a reliable test for fatty liver disease?
The ratio shows moderate accuracy, with an area under the curve of 0.701 in a 2026 study. It can help identify people at higher risk, but it should not replace liver ultrasound or a doctor’s evaluation for a diagnosis.
What can I do to lower my risk of fatty liver disease?
Research supports regular physical activity, balanced meals, limiting sugary drinks, and maintaining healthy blood sugar and cholesterol. If your fasting glucose to HDL ratio is high, ask your doctor about liver testing and a personalized plan.
Want to Apply This Research?
- Log your fasting blood glucose (mg/dL) and HDL cholesterol (mg/dL) from each lab report, then have the app calculate your ratio by dividing glucose by HDL. Set a flag for ratios at or above 3.87, the cutoff identified in the study, and prompt a conversation with your doctor when the value is reached. Record the date of each test so trends are easy to see.
- Encourage a weekly goal of at least 150 minutes of moderate activity, such as brisk walking, and a daily habit of swapping one sugary drink for water or unsweetened tea. Use the app to log these choices alongside your ratio so you can see whether daily habits and lab trends move in the same direction over time.
- Plan to check the ratio at each routine blood test, typically once or twice a year, and track results across several years rather than reacting to a single value. Pair the ratio with other health markers your doctor monitors, and review trends with your clinician at regular visits. Remind users that the ratio is a screening signal, not a diagnosis.
This article summarizes a single observational study and is for general education only. It is not medical advice and does not diagnose, treat, or prevent any condition. The study found an association between a blood ratio and fatty liver disease in one group of adults in China, which does not prove cause and effect. Talk with a qualified healthcare provider before making changes to your diet, exercise, or medications, and seek professional evaluation for any liver-related concerns.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.